Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy

Kidney International

Volumn 54, Issue 2, 1998, Pages 618-626

  Cannella, Giuseppe ^a   Paoletti, Ernesto ^a   Barocci, Sergio ^a   Massarino, Fabio ^a   Delfino, Roberto ^a   Ravera, Giambattista ^a   Di Maio, Giovanni ^a   Nocera, Arcangelo ^a   Patrone, Pietro ^a   Rolla, Davide ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

ACE gene genotype; ACE inhibitors; Arterial hypertension; Chronic uremia; Hemodialysis; LVH

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; NIFEDIPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UREMIA;

EID: 7344263515     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00027.x     Document Type: Article

References (45)

1. LONDON GM, FABIANI F: Left ventricular dysfunction in end-stage renal disease. Echocardiographic insights, in Cardiac Dysfunction in Chronic Uremia, edited by PARFREY PS, HARNETT JD, Basel, Kluwer Academic Publishers, 1992, pp 117-137
2. CANNELLA G, PAOLETTI E, DELFINO R, PELOSO GC, MOLINARI S, TRAVERSO GB: Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 44:881-886, 1993
3. CANNELLA G, PAOLETTI E: Myocardial hypertrophy in chronic renal failure: A multifactorial, reversible alteration. Contrib Nephrol 119: 135-140, 1996
4. CANNELLA G, PAOLETTI E, DELFINO R, PELOSO GC, ROLLA D, MOLINARI S: Prolonged therapy with ACE-inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremics independently from hypotensive effects. Am J Kidney Dis 30:659-664, 1997
5. MESSERLI FH: Pathophysiology of left ventricular hypertrophy, in Left Ventricular Hypertrophy and Its Regression, edited by CRUICKSHANK KJM, MESSERLI FH, London, Science Press, 1992, pp 13-20
6. SOUBRIER F, ALHENC-GELAS F, HUBERT C, ALLEGRINI J, JOHN M, TREGEAR G, CORVOL P: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386-9390, 1988
7. SCHUNKERT H, HENSE HW, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GAJ: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
8. SARGENT JA, GOTCH FA: Mathematic modeling of dialysis therapy. Kidney Int 18(Suppl 10):S2-S10, 1980
9. HEYKA RJ, PAGANINI EP: Blood pressure control in chronic dialysis patients, in Replacement of Renal Function by Dialysis (3rd ed), edited by MAHER JF, Basel, Kluwer Academic Publishers, 1989, pp 772-787
10. MCROURKE RA, HANRATH P, HENRY WN, HUGENHOLTZ PG, PISA Z, ROELANDT J, TANAKA M: Report of the Joint International Society and Federation of Cardiology/World Health Organization task force: Recommendations for standardization of measurements from M-mode echocardiograms. Circulation 69:854A-857A, 1984
11. CANNELLA G, LACANNA G, SANDRINI M, GAGGIOTTI M, NORDIO G, MOVILLI E, MOMBELLONI S, VISIOLI O, MAIORCA R: Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephrol Dial Transplant 6:31-37, 1991
12. DEVEREUX RB, ALONSO DR, LUTAS EM, GOTTLIEB GJ, CAMPO E, SACHS I, REICHEK N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57:450-458, 1986
13. OLERUP O, ZETTEROUIST H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225-235, 1992
14. GUSTINCICH S, MAFFIOLETTI G, DEL SAL G, SCHNEIDER C, CARNINCI P: A fast method for high quality genomic DNA extraction from whole human blood. Bio Techniques 1:298-302, 1991
15. SCHMIDT S, STIER E, HARTUNG R, STEIN G, BAHNISH J, WOODROFFE AJ, CLARKSON R, PONTICELLI C, CAMPISE M, MAYER G, GANTEN D, RITZ E: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 26:727-731, 1995
16. LINDPAINTNER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GRODSTEIN F, LAMOTTE F, BURING J, HENNEKENS CH: A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711, 1995
17. LOWRIE EG, TEEHAN BP: Principles of prescribing dialysis therapy: Implementing recommendations from the National Cooperative Dialysis Study. Kidney Int 23(Suppl 13):S113-S122, 1983
18. OTT J: Analysis of Human Linkage (2nd ed). Baltimore, John Hopkins University Press, 1991
19. SCHMIDT A, KIENER HP, BARNAS U, ARIAS I, ILLIEVICH A, AUINGER M, GRANINGER W, KAIDER A, MAYER G: Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 7:314-317, 1996
20. FOGARTY DG, MAXWELL AP, DOHERTY CC, HUGHES AE, NEVIN NC: ACE gene typing. (letter) Lancet 343:851, 1994
21. YOSHIDA H, KON V, ICHIKAWA I: Polymorphisms of the renin-angiotensin system genes in progressive renal diseases. Kidney Int 50:732-744, 1996
22. OSAKA N, YOSHIDA H, NAKAYAMA M, KUBO H, AIZAWA S, SATO S, NUMATA M, KAWAGUCHI Y, SAKAI O: ACE DD genotype predisposes patients on dialysis to cardiac accidents. (abstract) J Am Soc Nephrol 9:1396, 1996
23. LINDPAINTNER K, LEE MA, LARSON MG, SRINIVAS VR, PFEFFER MA, ORDOVAS JM, SCHAEFER EJ, WILSON AF, WILSON PWF, VASAN RS, MYERS RH, LEVY D: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 334:1023-1028, 1996
24. MONTGOMERY H: Should the contribution of ACE gene polymorphism to left ventricular hypertrophy be reconsidered? Heart 77:489-490, 1997
25. LEE MAE, PAUL M, BOHM M, GANTEN D: Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems. Am J Cardiol 70:12C-19C, 1992
26. DZAU VJ: Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 153:937-942, 1993
27. KENT RL, MANN DL, COOPER G: Signals for cardiac muscle hypertrophy in hypertension. J Cardiovasc Pharmacol 17:S7-S13, 1991
28. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
29. DANSER JAH, SCHALEKAMP MADH, BAX WA, VAN DEN BRINK AM, SAXENA PR, RIEGGER GAJ, SCHUNKERT H: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388, 1995
30. UEDA S, ELLIOTT HL, MORTON JJ, CONNELL MC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25: 1266-1269, 1995
31. FRANZ IW, KETELHUT R, BEHR U, TONNESMANN U: Long-term studies on regression of left ventricular hypertrophy. J Cardiovasc Pharmacol 17:S87-S93, 1991
32. LINZ W, SCHOLKENS BA, GANTEN D: Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats, Clin Exp Hypertension 11:1325-1350, 1989
33. LONDON GM, PANNIER B, GUERIN AP, MARCHAIS SJ, SAFAR ME, CUCHE JL: Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 90:2786-2796, 1994
34. SUZUKI H, SCHAEFER L, LING H, SCHAEFER RM, DAMMRICH J, TESCHNER M, HEIDLAND A: Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration: Potential roles of lysosomal proteinases. Am J Nephrol 15:129-136, 1995
35. GHARAVI AG, LIPKOWITZ MS, DIAMOND JA, JHANG JS, PHILLIPS RA: Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol 77:1315-1319, 1996
36. BLOEM LJ, MANATUNGA AK, PRATT JH: Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 27:62-66, 1996
37. HARRAP SB, DAVIDSON HR, CONNOR JM, SOUBRIER F, CORVOL P, FRASER R, FOY CJW, WATT GCM: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 21:455-460, 1993
38. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma levels. Am J Hum Genet 51:197-205, 1992
39. NISHIMURA H, HOFFMANN S, BALTATU O, SUGIMURA K, GANTEN D, URATA H: Angiotensin I converting enzyme and chymase in cardiovascular tissues. Kidney Int 49(Suppl 55):S18-S23, 1996
40. HARNETT JD, KENT GM, BARRE PE, TAVLOR R, PARFREY PS: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 4:1486-1490, 1994
41. DE LIMA JJG, ABENSUR H, KRIEGER EM, PILEGGI F: Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients. J Hypertens 14:1019-1024, 1996
42. CANNELLA G, PAOLETTI E: Clues for understanding the pathogenesis of left ventricular hypertrophy in chronic uremia. Int J Artif Organs (in press)
43. WEIR MR, GRAY JM, PASTER R, SAUNDERS E, FOR THE TRANDOLAPRIL MULTICENTFR STUDY GROUP: Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension 25:124-130, 1995
44. HINGORANI AD, JIA H, STEVENS PA, HOPPER R, DICKERSON JEC, BROWN MJ: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 13:1602-1609, 1995
45. JOHNSTON CI: Angiotensin receptor antagonists: Focus on losartan. Lancet 346:1403-1407, 1995